Morgan Stanley (NYSE:MS) analysts have upgraded Vir Biotechnology (NASDAQ:VIR) to an "overweight" rating, shifting from "equal-weight," and have also increased their price target to $20 from $10. The ...
Global brokerage Goldman Sachs on Thursday lowered its target price for Reliance Industries Ltd (RIL), while maintaining 'buy' rating for the diversified group. The brokerage reduced RIL's target ...
Major American banks are fleeing an international agreement to align their lending and investments with the goal of reaching net zero carbon emissions by 2050, in what some analysts see as a political ...